JAKARTA: Indonesia’s state-owned pharmaceutical company PT Kimia Farma is delaying a plan to sell Covid-19 vaccines after public backlash against the move.
The company will focus on preparing the programme first, said Ganti Winarno Putro, a spokesman for the company. Kimia Farma was earlier set to market Sinopharm Group Co shots, which were ordered for a private vaccination programme, as early as yesterday. The plan was met with questions on why the vaccines were being sold and why any company was allowed to profit from it.